We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Virtual Heart Technology Guides Cardiac Ablation Procedures

By HospiMedica International staff writers
Posted on 04 Oct 2018
A new study describes how personalized three-dimensional (3D) simulations can pinpoint infarct-related ventricular tachycardia (VT) ablation sites.

Developed by researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Simula Research Laboratory (Simula; Fornebu, Norway), the University of Utah (Salt Lake City, USA), and other institutions, the 3D personalized computational models are based on contrast-enhanced clinical magnetic resonance imaging (MRI) cardiac scans, with each virtual tissue cell generating electrical signals calculated using mathematical equations to represent which heart cells are healthy, and which are semiviable due to proximity to the infarction scar.

By stimulating the patient’s virtual heart, the computer program can determine if the heart develops an arrhythmia, and the location of the tissue perpetuating it. More...
The 3D model can then simulate an ablation to that area. The procedure can be repeated over and over again to find multiple ablation locations for the actual patient. For the study, the researchers first created personalized heart models of 21 people who underwent successful cardiac ablation procedures for infarct-related VT at JHU Hospital between 2006 and 2017. The 3D modeling correctly identified and predicted ablation sites.

In five of the patients, the amount of ablated tissue identified by the 3D model was smaller overall--in some cases, more than 10 times smaller--than the actual area destroyed during the procedures. The researchers then tested the 3D simulation to guide actual cardiac ablation treatments for another five patients. Most patients have remained free of VT throughout the follow-up period. In two patients, the virtual heart approach predicted that tachycardias would not be inducible, which was confirmed during the clinical procedure, so cardiac ablation was not performed. The study was published on September 3, 2018, in Nature Biomedical Engineering.

“Our new study results suggest we can remove a lot of the guesswork, standardize treatment, and decrease the variability in outcomes, so that patients remain free of arrhythmia in the long term,” said senior author Professor Natalia Trayanova, PhD, of the JHU department of biomedical engineering. “The approach could improve infarct-related VT ablation guidance, where accurate identification of patient-specific optimal targets could be achieved on a personalized virtual heart before the clinical procedure.”

In VT, the electrical signals in the heart’s lower chambers misfire, crippling the relaxation and refilling process and producing rapid arrhythmias. Numerous drugs are available to treat and manage infarct-related VT, but side effects and limitations of the drugs have increased focus on other interventions, especially cardiac ablation, which is successful anywhere between 50 and 88 percent of the time, but the outcomes are difficult to predict.

Related Links:
Johns Hopkins University
Simula Research Laboratory
University of Utah

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.